FGP
STAA icon

Freestone Grove Partners’s STAAR Surgical STAA Stock Holding History

Freestone Grove Partners’s Portfolio STAA Stock Details STAA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-54,960
Closed -$1.33M – 774
2024
Q4 		$1.33M Buy
+54,960
New +$1.57M 0.02% 284

Other funds holding STAA

BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
RAM
Resona Asset Management Koto-Ku,tokyo, Japan $20.1B AUM 26.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
YC
Yunqi Capital Hong Kong $92.4M AUM 16.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ACM
American Capital Management New York $1.86B AUM 20.23% 1-Year Est. Return

Freestone Grove Partners's STAA Position: Q1 2025 in Review

Freestone Grove Partners sold out of STAAR Surgical (STAA) in Q1 2025, closing a stake of 54,960 shares — an estimated $1.33M sold.

Freestone Grove Partners first reported a position in STAA in Q4 2024 and held it in 1 quarter. The position peaked at $1.33M in Q4 2024. 185 funds tracked by Wall St. Rank hold STAA as of Q1 2025.

  • Freestone Grove Partners reported no remaining STAAR Surgical position as of Q1 2025 after selling out during the quarter.
  • Freestone Grove Partners sold 54,960 STAAR Surgical shares in Q1 2025, an estimated $1.33M.
  • Freestone Grove Partners first reported a position in STAAR Surgical in Q4 2024 and held it in 1 quarter.
  • Freestone Grove Partners's STAAR Surgical position peaked at $1.33M in Q4 2024.
  • 185 funds tracked by Wall St. Rank held STAAR Surgical as of Q1 2025.

Based on Freestone Grove Partners's 13F filing for Q1 2025, filed 15 May 2025.